RESILIENT Resilience and Sensitivity in Early-Life Microbiome-Immune Development: A Mathematical Modeling Approach Across Diverse Pediatric Populations
- Coordinator
- Universitat Basel, Switzerland
- Runs
- 1 June 2027 to 31 May 2032
- Status
- Running
- EU funding
- €2.3m
- Total cost
- €2.3m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101300332
What the project is doing
In the project's own words, from its summary on CORDIS.
Disruptions to the gut microbiome during early-life can shape immune development and lifelong health, yet most infants achieve typical outcomes despite varied exposures. This heterogeneity reveals a simple question with major clinical impact: why do some perturbations fade while others lead toward chronic disease? RESILIENT establishes the first quantitative systems biology framework to model developmental resilience in microbiome-immune co-development, identifying when, for whom, and through which pathways perturbations have lasting consequences.
By synthesizing longitudinal multi-omics data from diverse pediatric cohorts, we will model development as a trajectory through discrete states in microbiome composition, gut barrier function, gut, and systemic immunity. Novel case-control matching will isolate the effects of postnatal perturbations—antibiotics, feeding transitions, infections—by comparing infants to counterfactual trajectories with similar histories, identifying critical windows of maximal impact and quantifying how long effects persist.
Markov transition models will test whether perinatal conditions—birth mode, gestational age, colostrum intake—create biological memory by constraining infants' capacity to transition to healthy states beyond what their current state predicts. Granger causality analysis will identify which cross-domain connections propagate long-term effects of early-life perturbations, distinguishing strong causal pathways from spurious associations.
We will formalize these insights into a mechanistic mathematical model, enabling in silico experimentation to optimize pediatric interventions such as antibiotic stewardship, probiotics, and feeding practices. By transforming developmental resilience from a qualitative concept into a quantifiable, predictive property, RESILIENT identifies which infants require early intervention before pathological programming becomes irreversible—enabling a shift from reactive to proactive pediatric care.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitat Basel | Basel | Switzerland | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI